Home » Topics » Regulatory » Patents

Patents
RSS

Xiamen University describes ALK and/or c-Met inhibitors

Nov. 15, 2016

Katholieke Universiteit Leuven discloses PMDT nucleoside phosphonates

Nov. 15, 2016

Texas A&M University patents antimycobacterial agents

Nov. 15, 2016

Medshine Discovery presents JAK2 inhibitors

Nov. 14, 2016

The Vanderbilt University discloses M1 receptor PAMs

Nov. 14, 2016

Constellation Pharmaceuticals prepares and tests LSD1 inhibitors

Nov. 14, 2016

Harvard College reports insulin-degrading enzyme inhibitors

Nov. 14, 2016

Recent Esteve patent describes sigma1 receptor ligands for pain

Nov. 14, 2016

Inhibikase Therapeutics describes tyrosine kinase inhibitors

Nov. 11, 2016

BGI-Shenzhen develops of calcium channel blockers

Nov. 11, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...